Great Lakes Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-1,299	Closed	-$316K	–	833
2024 Q2	$316K	Buy	+1,299	New	+$205K	﹤0.01%	722
2024 Q1	–	Sell	-1,406	Closed	-$269K	–	806
2023 Q4	$269K	Sell	1,406 -39	-3%	-$6.64K	﹤0.01%	692
2023 Q3	$256K	Sell	1,445 -73	-5%	-$13.9K	﹤0.01%	682
2023 Q2	$288K	Buy	+1,518	New	+$301K	﹤0.01%	649
2021 Q2	–	Sell	-6,565	Closed	-$927K	–	706
2021 Q1	$927K	Buy	6,565 +256	+4%	+$38.5K	0.02%	454
2020 Q4	$820K	Buy	6,309 +1	+0%	+$134	0.01%	441
2020 Q3	$918K	Sell	6,308 -1,462	-19%	-$208K	0.02%	411
2020 Q2	$1.15M	Sell	7,770 -84	-1%	-$11.3K	0.03%	385
2020 Q1	$855K	Buy	+7,854	New	+$907K	0.03%	393
2019 Q4	–	Sell	-150,601	Closed	-$12.1M	–	558
2019 Q3	$12.1M	Buy	+150,601	New	+$11.9M	0.27%	96
2015 Q3	–	Sell	-5,433	Closed	-$651K	–	527
2015 Q2	$651K	Buy	+5,433	New	+$649K	0.02%	394